Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.

Tumour Biol

Department of Integrative Medicine of Traditional Chinese Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.

Published: November 2014

Genetic variations in the xeroderma pigmentosum group D (XPD) gene may increase cancer susceptibility by affecting the capacity for DNA repair. A lot of studies have reported the association of XPD Lys751Gln polymorphism with risk of cancer, but the results remained controversial. Hence, we performed a systematic review and conducted a meta-analysis to explore association of the XPD Lys751Gln polymorphism with risk of cancer (78,398 cases and 103,178 controls from 224 studies). Overall, a significantly increased cancer risk was found in all genetic models (dominant model: odds ratio (OR) = 1.10, 95% confidence interval (CI) = 1.06-1.14; recessive model: OR = 1.10, 95% CI = 1.05-1.15; homozygous model: OR = 1.14, 95% CI = 1.08-1.21; heterozygous model: OR = 1.09, 95% CI = 1.05-1.12; additive model: OR = 1.08, 95% CI= 1.05-1.11) when all eligible studies were pooled into the meta-analysis. In further stratified and sensitivity analyses, the elevated risk of cancer remained for subgroups of breast cancer, esophageal cancer, hepatocellular cancer, leukemia, lung cancer, and melanoma. In summary, this meta-analysis suggests the XPD Lys751Gln polymorphism is a genetic susceptibility for some cancer types. Moreover, ethnicity, histological type of cancer, and smokers seem to contribute to varying expressions of the Lys751Gln on some cancer risk. In addition, our work also points out the importance of new studies for Lys751Gln association in endometrial cancer and ovarian cancer, where at least some of the covariates responsible for heterogeneity could be controlled, to obtain a more conclusive understanding about the function of the Lys751Gln polymorphism in cancer development.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-014-2379-xDOI Listing

Publication Analysis

Top Keywords

lys751gln polymorphism
20
cancer
16
risk cancer
16
polymorphism risk
12
xpd lys751gln
12
association xpd
8
cancer remained
8
cancer risk
8
110 95%
8
lys751gln
7

Similar Publications

Article Synopsis
  • Human Excision Repair Cross-Complementation Group 2 (ERCC2) proteins are crucial for the nucleotide excision repair pathway, and polymorphisms in the ERCC2 gene are linked to cancer susceptibility, though previous findings were inconsistent.
  • This study aimed to explore the connection between specific ERCC2 genetic polymorphisms at codons 312 and 751 and the risk and aggressiveness of bladder cancer in Bangladeshi patients.
  • Results indicated that individuals with certain ERCC2 polymorphisms, particularly Gln/Gln at codon 751 and Asp/Asn at codon 312, had a significantly higher risk of developing bladder cancer, especially among those with a family history of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Prostate cancer diagnosis in Bangladesh is low due to lack of awareness and screening, causing high mortality rates, leading researchers to evaluate specific genetic markers for risk assessment.
  • The study analyzed 132 prostate cancer patients and 135 healthy controls, finding that the XRCC1 Trp/Trp genotype is linked to an increased risk of prostate cancer, while no significant risk was associated with the XPD variant.
  • The results indicate that XRCC1 could serve as a potential biomarker for early prostate cancer diagnosis, highlighting the need for improved screening methods in Bangladesh.
View Article and Find Full Text PDF

The Role of DNA Repair (, , , and Gene Polymorphisms in the Development of Myeloproliferative Neoplasms.

Medicina (Kaunas)

March 2024

Genetics Department, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu 38, 540142 Targu Mures, Romania.

: Several polymorphisms have been described in various DNA repair genes. Nucleotide excision DNA repair (NER) detects defects of DNA molecules and corrects them to restore genome integrity. We hypothesized that the , , , and gene polymorphisms influence the appearance of myeloproliferative neoplasms (MPNs).

View Article and Find Full Text PDF

Background: Studies on single nucleotide polymorphisms (SNPs) in non-small cell lung cancer (NSCLC) suggest that DNA repair capacity may have prognostic implications for disease recurrence and survival. However, there is no study investigating the relationship between SNPs and the risk of metastasis at the time of initial diagnosis in patients with NSCLC.

Objective: This study aimed to investigate the potential predictive value of SNPs in detecting the risk of metastasis at the time of initial diagnosis and poor prognosis in patients with NSCLC.

View Article and Find Full Text PDF

Background: The aim of the study is to understand the association of Nucleotide excision repair (NER) inter-genetic polymorphic combinations with overall survival (OS) in lung cancer as well as its histological subtypes in the North Indian population.

Materials And Methods: Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism. For survival analysis, the univariate Kaplan-Meier and multivariate Cox regression model were applied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!